23
Participants
Start Date
March 31, 2012
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
imatinib
The patients will receive 400 mg per day of imatinib for 4 weeks, and then 600mg per day (300 mg po bid) for 4 weeks if tolerable to 400 mg per day, and then 800 mg per day (400 mg po bid)
Asan Medical Center, University of Ulsan College of Medicine, Seoul
Lead Sponsor
Asan Medical Center
OTHER